Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.

Annals of transplantation : quarterly of the Polish Transplantation Society

Volumn 11, Issue 2, 2006, Pages 51-56

  Boratyńska, Maria ^a   Banasik, Mirosław ^a   Patrzałek, Dariusz ^a   Klinger, Marian ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ALLOTRANSPLANTATION; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MORTALITY; PHYSIOLOGY; REVIEW; SURVIVAL; TIME;

CYCLOSPORINE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; SURVIVAL ANALYSIS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34250331658     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)